FLNA:BMV
Filana Therapeutics Inc
15,92 MXN
0,00%
(0,00) 1 D.
10-05, 12:05:31 GMT−6 · MXN
search
Visi simboliai
| Simbolis | Kaina | Keisti | Pokytis, % |
|---|
insights_autoGeneruojamos svarbiausios „FLNA“ įžvalgos...
Rinkos kapitalizacija
35,50 mln.
Vid. kiekis
0,00
Apimtis
0,00
52 sav. aukšta
56,00 MXN
52 sav. žema
15,92 MXN
Darbuotojų skaičius
19
Rinkos kapitalizacija
35,50 mln.
Vid. kiekis
0,00
Apimtis
0,00
52 sav. aukšta
56,00 MXN
52 sav. žema
15,92 MXN
Darbuotojų skaičius
19
Naujienų istorijos
Iš žiniatinklio šaltinių ir naujienų partnerių
Traders.lt
·
prieš 2 dienas
Prognozuoja didžiausią S&P500 kritimą nuo 2008 metų
Stocktwits
·
prieš 1 valandą
S&P 500, Nasdaq See Worst Day In Over Two Months As Chipmaker Rout Deepens, CPI Data Comes In Hot — AAPL, SPCX, DRAM, SOXX In Focus
MarketBeat
·
prieš 15 minučių
CoreWeave (NASDAQ:CRWV) CRO Jonathan Jones Sells 15,811 Shares of Stock
Bloomberg.com
·
prieš 4 valandas
S&P 500 Ends Longest Streak of Calm Since 2020 as AI Trade Sinks
Profilis
Filana Therapeutics, Inc. is an American pharmaceutical company based in Austin, Texas. Currently led by President and CEO Richard Barry, Filana is working on developing simufilam to treat tuberous sclerosis complex–related epilepsy. The company previously was developing simufilam as an oral-tablet drug candidate for the treatment of Alzheimer's disease. Development of simufilam was discontinued in November 2024 after it failed to show clinical benefit in phase III clinical trials.
In June 2024, the United States Department of Justice charged an advisor to Cassava Hoau-Yan Wang, with fraud over research results related to the experimental drug. Less than a month later, the president, chief executive officer and chairman of the board, Remi Barbier, resigned along with Lindsay Burns, his wife, who was the company's senior vice president and Wang's co-author. The U.S. Securities and Exchange Commission filed fraud charges in September 2024 against Barbier, Burns and Wang. The parties did not admit wrongdoing, but agreed to pay fines of the company $40 million, Barbier $175,000, Burns $85,000, and Wang $50,000. Wikipedia
Apie „Filana Therapeutics Inc“
Generalinis direktorius-
Darbuotojai19
Įkurta1998
Pagrindinė būstinėOstinas, Teksasas, Jungtinės Valstijos
Sektorius-
Svetainėpaintrials.com